Experience

Jiangsu Hengrui Pharmaceuticals Announces License Agreement With Merck

March 25, 2025

Cooley advised Jiangsu Hengrui Pharmaceuticals (Hengrui Pharma), a global pharmaceutical company focused on scientific and technological innovation, on its exclusive license agreement with Merck (NYSE: MRK), known as MSD outside of the US and Canada, for HRS-5346, an investigational oral small molecule lipoprotein(a), or Lp(a), inhibitor currently being evaluated in a phase 2 clinical trial in China.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Jiqiang Lin
Associate, New York
Andrew Epstein
Special Counsel, Seattle
Zhijing Yu
Associate, Singapore
David Burns
Special Counsel, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
Navya Dasari
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Robert Eisenbach
Of Counsel, San Francisco
Russell Anderson
Partner, London
Megan Browdie
Partner, Washington, DC
Steve Przesmicki
Partner, San Diego

Related Practices & Industries

Longboard Pharmaceuticals Announces $2.6 Billion Sale to Lundbeck

October 14, 2024

Cooley advised Longboard Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, on its $2.6 billion sale to Lundbeck.

Read more

Related contacts

Kevin Cooper
Partner, New York
Steve Przesmicki
Partner, San Diego
Alessandra Murata
Partner, Palo Alto
David Burns
Special Counsel, Washington, DC
Jenny Ge
Associate, Santa Monica
Jeewon Lee
Associate, New York
Charity Williams
Partner, San Diego
Son Nguyen
Special Counsel, Washington, DC
Stella Sarma
Partner, Brussels
Cara Buchicchio
Associate, New York
Jameson Davis
Associate, Boston
Sela Dougherty
Associate, Miami
Rubin Waranch
Associate, Colorado

Related Practices & Industries

AGS Announces Definitive Agreement to Be Acquired by Brightstar Capital Partners for $1.1 Billion

May 9, 2024

Cooley advised PlayAGS, a global gaming supplier of high-performing slots, tables and interactive products, on its definitive agreement to be acquired by the affiliates of Brightstar Capital Partners for $1.1 billion.

Read more

Related contacts

Miguel J. Vega
Partner, Boston
Steve Przesmicki
Partner, San Diego
David Silverman
Partner, New York
Natalie D. Vernon
Associate, Colorado
Rachel Shapiro
Associate, Colorado
Barbara Mirza
Partner, Santa Monica
Alexander Ellebracht
Associate, Palo Alto
Alexandra Leavy
Associate, New York
Peter Adams
Partner, San Diego
Megan Browdie
Partner, Washington, DC
Thomas Connors
Partner, Boston
Kevin Cooper
Partner, New York
Ross Eberly
Partner, Santa Monica
Patrick Flanagan
Partner, New York
Todd Gluth
Partner, San Diego
Christine Graham
Special Counsel, London
Stella Sarma
Partner, Brussels
Karen Tsai
Special Counsel, Washington, DC
Alexis Guillermo Buz
Associate, San Diego
James Christopher
Associate, Boston
Joshua Elefant
Associate, Palo Alto
Jimmy Gilligan
Associate, Boston
Katie Kaufman
Associate, Boston
Allison Kutner
Associate, New York
Kyrsten Lundh
Associate, San Diego
Sangitha Palaniappa
Associate, Palo Alto
María Álvarez Requejo Heredero
Associate, Brussels
Sarah Buchik
Associate, New York

Related Practices & Industries

Seven and Eight Biopharma Announces Global License, Collaboration Agreement With Eikon

June 14, 2023

Cooley advised Seven and Eight Biopharmaceuticals, clinical-stage biotechnology company focused on the development and commercialization of novel immunotherapies for cancer, on its license and collaboration agreement with Eikon Therapeutics, a biotechnology company.

Read more

Related contacts

Lila Hope
Partner, Palo Alto
Steve Przesmicki
Partner, San Diego
Bin Wang
Special Counsel, Palo Alto
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion

December 15, 2021

Cooley advised Arena Pharmaceuticals, a clinical-stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases, on its definitive agreement to sell to Pfizer for $6.7 billion. Partners Jamie Leigh, Kevin Cooper and Steve Przesmicki led the Cooley team advising Arena.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
Kevin Cooper
Partner, New York
Steve Przesmicki
Partner, San Diego
Jeffrey J. Tolin
Partner, New York
Barbara Mirza
Partner, Santa Monica
Peter Adams
Partner, San Diego
Phil Mitchell
Partner, New York
Mika Reiner Mayer
Partner, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Christine Graham
Special Counsel, London
Stella Sarma
Partner, Brussels
Asa Henin
Partner, San Diego
Sangitha Palaniappa
Associate, Palo Alto
Heidi E. Wang
Associate, San Diego
Peter Burns
Of Counsel, Palo Alto
Eileen Leman
Associate, Los Angeles
Ross Eberly
Partner, Santa Monica
Kyrsten Lundh
Associate, San Diego
Patrick Sharma
Associate, Santa Monica
Allison Kutner
Associate, New York
Andrew Epstein
Special Counsel, Seattle
Dionne A. Thomas
Associate, San Diego
Dr. Madhuri Roy
Partner, Palo Alto

Related Practices & Industries

View more

Admissions and credentials

California

Wisconsin

Rankings and accolades

Best Lawyers in America: Corporate Law

San Diego Super Lawyers

Southern California Super Lawyers